These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 19576064)

  • 1. [Pharmacologic vitreolysis in diabetic rats].
    Luo M; Wang ZL; Shi WD; Fan XQ; Xu GT
    Zhonghua Yan Ke Za Zhi; 2009 May; 45(5):417-23. PubMed ID: 19576064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic vitreolysis with plasmin and hyaluronidase in diabetic rats.
    Zhi-Liang W; Wo-Dong S; Min L; Xiao-Ping B; Jin J
    Retina; 2009 Feb; 29(2):269-74. PubMed ID: 19050667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic vitreolysis in diabetic retinopathy.
    El-Asrar AM; Al-Mezain HS
    Curr Pharm Biotechnol; 2011 Mar; 12(3):406-9. PubMed ID: 20939804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic vitreolysis combining the two enzymes plasmin and hyaluronidase.
    Gandorfer A; Kampik A
    Retina; 2005; 25(5):674; author reply 674-5. PubMed ID: 16077373
    [No Abstract]   [Full Text] [Related]  

  • 5. Enzymatic vitreolysis.
    Lopez-Lopez F; Rodriguez-Blanco M; Gómez-Ulla F; Marticorena J
    Curr Diabetes Rev; 2009 Feb; 5(1):57-62. PubMed ID: 19199900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An experimental study on dissolving and detaching vitreoretinal interface with enzymes].
    Wang LF; Ma JX; Liu JZ; Cai SZ; Lu LC; Wang ZD
    Zhonghua Yan Ke Za Zhi; 2004 Jul; 40(7):459-64. PubMed ID: 15454060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme-induced vitreolysis can alleviate the progression of diabetic retinopathy through the HIF-1α pathway.
    Li C; Chen P; Zhang J; Zhang L; Huang X; Yao Y; Che X; Fan X; Ge S; Wang Z
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4964-70. PubMed ID: 23847321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel vitreous modulators for pharmacologic vitreolysis in the treatment of diabetic retinopathy.
    Costa Ede P; Rodrigues EB; Farah ME; Sebag J; Meyer CH
    Curr Pharm Biotechnol; 2011 Mar; 12(3):410-22. PubMed ID: 20939794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrasurgical plasmin enzyme in diabetic macular edema.
    Azzolini C; D'Angelo A; Maestranzi G; Codenotti M; Della Valle P; Prati M; Brancato R
    Am J Ophthalmol; 2004 Oct; 138(4):560-6. PubMed ID: 15488781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrasurgical plasmin enzyme in diabetic macular edema.
    Gandorfer A; Kampik A
    Am J Ophthalmol; 2005 May; 139(5):949; author reply 949-50. PubMed ID: 15860323
    [No Abstract]   [Full Text] [Related]  

  • 11. PVD following plasmin but not hyaluronidase: implications for combination pharmacologic vitreolysis therapy.
    Wang ZL; Zhang X; Xu X; Sun XD; Wang F
    Retina; 2005 Jan; 25(1):38-43. PubMed ID: 15655439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic vitreous disruption.
    Gandorfer A
    Eye (Lond); 2008 Oct; 22(10):1273-7. PubMed ID: 18292784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal injection of hyaluronidase cannot induce posterior vitreous detachment in the rabbit.
    Hikichi T; Kado M; Yoshida A
    Retina; 2000; 20(2):195-8. PubMed ID: 10783954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic vitreolysis.
    Gandorfer A
    Dev Ophthalmol; 2007; 39():149-156. PubMed ID: 17245084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic vitreolysis with ocriplasmin: rationale for use and therapeutic potential in vitreo-retinal disorders.
    Khoshnevis M; Sebag J
    BioDrugs; 2015 Apr; 29(2):103-12. PubMed ID: 25812991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biology of pharmacologic vitreolysis.
    Sebag J
    Trans Am Ophthalmol Soc; 2005; 103():473-94. PubMed ID: 17057814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative responses induced by pharmacologic vitreolysis and/or long-term hyperoxia treatment in rat lenses.
    Li Q; Yan H; Ding TB; Han J; Shui YB; Beebe DC
    Curr Eye Res; 2013 Jun; 38(6):639-48. PubMed ID: 23534693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effect of plasmin on the vitreolysis in rabbit eyes.
    Kim NJ; Yu HG; Yu YS; Chung H
    Korean J Ophthalmol; 2004 Jun; 18(1):35-40. PubMed ID: 15255235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of the anterior vitreous detachment induced by microplasmin, or pharmacologic vitreolysis to separate the posterior capsule from the anterior hyaloid.
    Van Looveren J; Tassignon MJ; De Smet M
    Bull Soc Belge Ophtalmol; 2011; (317):51-2. PubMed ID: 21560858
    [No Abstract]   [Full Text] [Related]  

  • 20. Enzyme-assisted vitrectomy in enucleated pig eyes: a comparison of hyaluronidase, chondroitinase, and plasmin.
    Staubach F; Nober V; Janknecht P
    Curr Eye Res; 2004; 29(4-5):261-8. PubMed ID: 15590471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.